EUVIMEDEUVIMED entdecken
Crossref

Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?

Sinan Altunoz iD, Nazan Dolapoglu iD, Ozgur Baykan iD, Hilmi Bolat iD, Ayla Solmaz Avcikurt iD, Tunay Karlidere iD

International Journal of Developmental Neuroscience · 2025

DOI: 10.1002/jdn.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2025. Verfasst von Sinan Altunoz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health and Diseases, Balikesir Atatürk City Hospital, Balikesir, Turkey. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, MicroRNAs, Transforming Growth Factor beta. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Balikesir University Scientific Research Projects Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study investigated the regulation of miRNA‐132‐3p on TGF‐β levels and its association with OCD severity. We hypothesized that miRNA‐132‐3p and TGF‐β influence OCD aetiology and severity, with their levels correlating with disease severity.

Methods

The study included 48 OCD patients diagnosed via SCID‐5‐CV per DSM‐V and 48 matched healthy controls. Blood samples were analysed for miRNA‐132‐3p and TGF‐β using RT‐PCR and ELISA. Participants completed Y‐BOCS, symptom list, HAMA, HAMD, consent and sociodemographic forms.

Results

OCD patients had significantly lower TGF‐β levels ( p = 0.008), negatively correlating with Y‐BOCS scores (r s = −0.220, p = 0.045) and disease duration (r s = −0.473, p = 0.002). miRNA‐132‐3p levels were 1.92 times higher in OCD patients ( p = 0.003), positively correlating with Y‐BOCS scores (r s = 0.208, p = 0.045).

Conclusions

Altered TGF‐β and miRNA‐132‐3p levels may contribute to OCD pathophysiology by affecting BDNF regulation, inflammatory responses (Th1/Th2, Th17/Treg balance) and synaptic plasticity‐related genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obsessive-Compulsive DisorderMicroRNAsTransforming Growth Factor betaHumansMaleFemaleAdultBiomarkersSeverity of Illness IndexYoung AdultMiddle AgedPsychiatric Status Rating ScalesAdolescent

Stichwörter der Autor:innen

TGF‐βmiRNAobsessive‐compulsive disorder

Substanzen

MicroRNAsTransforming Growth Factor betaBiomarkersMIRN132 microRNA, human

Autor:innen und Institutionen

  • Department of Mental Health and Diseases, Balikesir Atatürk City Hospital, Balikesir, Turkey.
  • Department of Mental Health and Diseases, Balikesir University Faculty of Medicine, Balikesir, Turkey.
  • Department of Medical Biochemistry, Balikesir University Faculty of Medicine, Balikesir, Turkey.
  • Department of Medical Genetics, Balikesir University Faculty of Medicine, Balikesir, Turkey.
  • Department of Medical Biology, Balikesir University Faculty of Medicine, Balikesir, Turkey.

ORCID-Profile: Sinan Altunoz, Nazan Dolapoglu, Ozgur Baykan, Hilmi Bolat, Ayla Solmaz Avcikurt, Tunay Karlidere

Förderung

  • Balikesir University Scientific Research Projects Unit

Zitieren

APA

Altunoz, S., Dolapoglu, N., Baykan, O., Bolat, H., Avcikurt, A. S., & Karlidere, T. (2025). Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.70070

Vancouver

Altunoz S, Dolapoglu N, Baykan O, Bolat H, Avcikurt AS, Karlidere T. Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?. International Journal of Developmental Neuroscience. 2025. doi:10.1002/jdn.70070

BibTeX
@article{Altunoz2025,
  author = {Altunoz, Sinan and Dolapoglu, Nazan and Baykan, Ozgur and Bolat, Hilmi and Avcikurt, Ayla Solmaz and Karlidere, Tunay},
  title = {Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?},
  journal = {International Journal of Developmental Neuroscience},
  year = {2025},
  doi = {10.1002/jdn.70070}
}
Kostenlos starten →